- Series A
Vektor Medical is on a mission to revolutionize arrhythmia care. The FDA-cleared vMap technology, is an AI-based arrhythmia analysis tool, created to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency.
Robert J. KrummenFounder
I am the CEO of Vektor Medical, a company that leverages AI, computational intelligence, and data to improve patient outcomes and reduce procedure time and costs.
I joined Vektor Medical in 2018 as the Chief Operating Officer and General Counsel, and became the President and COO in 2021, before taking on the CEO role in 2022. I work with a talented and diverse team of engineers, scientists, clinicians, and business professionals. I have successfully led the company through multiple rounds of funding, regulatory approvals, product launches, and partnerships, while maintaining a culture of innovation, collaboration, and excellence.
Vektor Medical's mission is revolutionize arrhythmia care. We are working hard to transform care for patients suffering from heart rhythm disorders with AI, computational intelligence, and big data, while creating value for our customers, partners, investors, and employees.